Information  X 
Enter a valid email address

Unilever PLC (ULVR)

  Print          Annual reports

Thursday 10 February, 2022

Unilever PLC

Final Results

RNS Number : 2276B
Unilever PLC
10 February 2022
 

2021 FULL YEAR RESULTS

Performance highlights (unaudited)

Underlying performance

GAAP measures

 

 

vs 2020

 

 

vs 2020

Full Year

 

 

 

 

 

Underlying sales growth (USG)

 

4.5%

Turnover

€52.4bn

3.4%

Underlying operating profit

€9.6bn

2.9%

Operating profit

€8.7bn

4.8%

Underlying operating margin

18.4%

(10) bps

Operating margin

16.6%

20 bps

Underlying earnings per share

2.62

5.5%

Diluted earnings per share

2.32

9.2%

Free cash flow

 6.4bn

€(1.3)bn

Net profit

€6.6bn

9.0%

Fourth Quarter

 

 

 

 

 

USG

 

4.9%

Turnover

€13.1bn

8.4%

Quarterly dividend payable in March 2022

€0.4268 per share(a)

             

(a) See note 11 for more information on dividends.

Full year highlights

· Fastest underlying sales growth in nine years - 4.5%, with 2.9% price and 1.6% volume

· Turnover increased 3.4%, with a positive impact from acquisitions and a negative impact from currency

· Underlying operating profit increased 2.9% and underlying operating margin decreased by 10bps

· Underlying earnings per share increased 5.5% and diluted earnings per share 9.2%

· Announced the sale of Tea business for €4.5 billion, with completion expected in H2 2022 

· Completed €3 billion of share buybacks in 2021; announcing further €3 billion programme for 2022-2023

· Dividend per share growth of 3% for 2021

· Announced a simpler, more category-focused organisational model

 

Alan Jope: Chief Executive Officer statement

"The acceleration of Unilever's operating performance continues. We delivered our fastest underlying sales growth for nine years - 4.5% for the full year, with 1.6% from volume.

Our thirteen billion-Euro brands grew 6.4%. Priority markets of China, India, and the US grew at 14.3%, 13.4%, and 3.7% respectively. Our growth in e-commerce was 44%, ahead of global channel growth and bringing e-commerce to 13% of turnover. We have continued to re-shape our portfolio into high growth spaces, acquiring in Prestige Beauty and Functional Nutrition, and agreeing the sale of our Tea business.

The major challenge of 2021 has been the dramatic rise of input costs. We responded with pricing actions, delivering underlying price growth of 2.9% for the year, accelerating to 4.9% in the fourth quarter, with full year underlying operating margin down 10bps and underlying earnings per share up 5.5%.

We are focused on driving faster growth from our strong portfolio of brands and markets, and recently announced a major change to create a simpler, more category-focused organisation designed to further improve performance. In 2022, we will manage a significant input cost inflation cycle and will continue to invest competitively in marketing, R&D and capital expenditure.

We have engaged extensively with our shareholders in recent weeks and received a strong message that the evolution of our portfolio needs to be measured. We therefore do not intend to pursue major acquisitions in the foreseeable future and will conduct a share buyback programme of up to €3 billion over the next two years."

10 February 2022

 

Outlook for 2022

We expect underlying sales growth in 2022 to be in the range of 4.5% to 6.5%. Pricing will continue to be strong, with some impact on volume as a result.

 

We currently expect very high input cost inflation in the first half of over €2 billion. This may moderate in the second half to around €1.5 billion, although there is currently a wide range for this that reflects market uncertainty on the outlook for commodity, freight and packaging costs.

 

The new organisation is expected to generate around €600 million of cost savings over two years. We plan to maintain competitive levels of investment in marketing, R&D and capital expenditure through a period of inflation-led gross margin pressure until input costs normalise and the full extent of pricing is reflected. 

 

2022 underlying operating margin is expected to be down by between 140bps and 240bps, so maintained between 16% and 17%, with the first half impacted more than the second half. We expect margin to be restored after 2022, with the bulk coming back in 2023 and the rest in 2024.

 

Unilever's strong cash flow delivery will continue, and the Board has approved a share buyback programme of up to €3 billion to be conducted over the next two years, which we expect to commence in the first quarter.

 

Organisational change

In January 2022, we announced major changes to Unilever's organisation to make it simpler and more category-focused. Unilever will be organised around five category-focused Business Groups, each responsible and accountable for their strategy, growth and profit delivery; running their businesses in all geographies.

 

We expect our new organisation to be fully operational from the middle of the year. The new structure will be achieved within existing restructuring investment plans of €2 billion across 2021 and 2022. Restructuring investment for 2022 is therefore expected to be around €1.4 billion, returning to pre-2017 levels of around 1% of turnover thereafter. The new organisation is expected to generate around €600 million of cost savings over two years.

 

FULL YEAR OPERATIONAL REVIEW: DIVISIONS

 

 

Fourth Quarter 2021

Full Year 2021

(unaudited)

Turnover

USG

UVG

UPG

Turnover

USG

UVG

UPG

Change in underlying operating margin

 

€bn

%

%

%

€bn

%

%

%

bps

Unilever

13.1

4.9

-

4.9

52.4

4.5

1.6

2.9

(10)

Beauty & Personal Care

5.8

6.2

0.9

5.3

21.9

3.8

0.8

3.0

-

Home Care

2.7

5.0

(3.1)

8.4

10.6

3.9

0.7

3.1

(110)

Foods & Refreshment

4.6

3.2

0.6

2.5

19.9

5.6

2.9

2.7

40

Our markets: Very high input cost inflation has been widespread across our markets and is expected to continue. Covid-19 is having an ongoing impact on the operating environment, including in the final quarter of the year as new restrictions were implemented in some geographies.

In North America and Europe markets declined in 2021 as we lapped high demand in the prior year for in-home food and hygiene products. Covid-19 impacted India in the early part of the year. In China the market recovered well in 2021 but economic growth has started to slow. Markets in Latin America are recovering, with growth driven by higher prices, although macroeconomic volatility remains high. In South East Asia markets are improving following tough restrictions on daily life through 2021. In Turkey, economic conditions deteriorated throughout the fourth quarter.

Unilever overall performance: Stepping up competitive growth is our priority. In 2021, our five strategic priorities and focus on operational excellence delivered full year underlying sales growth of 4.5% with volume of 1.6% and price of 2.9%. In the fourth quarter price stepped up to 4.9% with volume flat, as our brands provided strong pricing power in an environment of rising commodity and other input costs. Foods and Refreshment grew fastest in 2021 with 5.6% underlying sales growth with food solutions and out-of-home ice cream partially recovering from channel restrictions in 2020.

In the US growth has returned to competitive levels, with strong contributions from Prestige Beauty, functional nutrition and food solutions. India grew double-digit with balanced volume and price and strong actions on savings and mix. China grew double-digit, led by volume, with growth broad-based across categories and channels, especially e-commerce.

Latin America grew high single-digit led by price with flat volume in a high inflation market. South East Asia declined following tough Covid-19 related restrictions throughout the year and weak competitive performance in Indonesia. Europe grew slightly from both price and volume.

Prestige Beauty delivered strong double-digit growth across all brands as channels reopened, with e-commerce a big contributor. Functional nutrition grew double-digit across the portfolio of brands.

E-commerce growth was 44% and now represents 13% of Unilever's turnover.

Turnover increased 3.4%. Underlying sales growth was 4.5%, there was a net positive impact of 1.3% from acquisitions and disposals and a negative impact of 2.4% from currency-related items.

Underlying operating profit was €9.6 billion, an increase of 2.9% including a negative impact from currency of 4.3%. Underlying operating margin decreased by 10bps. Gross margin decreased by 120bps reflecting very high inflation in raw material, packaging and distribution costs, partially offset by savings and pricing actions. Brand and marketing investment fell slightly but remained at competitive levels, and overheads benefitted from turnover leverage, making a positive impact of 90bps and 20bps respectively on underlying operating margin.

Free cash flow was €6.4 billion compared to €7.7 billion in 2020 as we increased capital expenditure and lapped the strong working capital improvement of 2020 which was maintained in 2021.

We have agreed to sell our global tea business, ekaterra ("Tea"), to CVC Capital Partners Fund VIII for €4.5 billion on a cash-free, debt-free basis. In full year 2020, ekaterra generated turnover of around €2 billion. The sale excludes Unilever's tea business in India, Nepal and Indonesia as well as Unilever's interests in the Pepsi Lipton ready-to-drink tea joint ventures and associated distribution businesses.

After reviewing options for Elida Beauty, we concluded that this business will create the most value managed as an independent unit within Unilever, with dedicated focus under our new operating model.

 

Beauty & Personal Care

Beauty & Personal Care underlying sales grew 3.8%, with 3.0% from price and 0.8% from volume. All categories delivered good growth apart from skin cleansing which declined following elevated demand in the prior year. Skin care grew high single-digit with channels reopening in 2021. Vaseline performed strongly throughout the year, supported by several premium innovations across brightening, therapeutics and hydration . Deodorants grew as the market continued to recover, with good growth and restored competitiveness in North America. Dove refillable deodorant launched in the US and has been well-received by consumers. Hair care grew mid-single-digit with Sunsilk, Dove and Clear contributing and styling in North America being restored to competitive growth. Oral care grew with good performance in South Asia and Africa. Prestige Beauty grew double-digit with all brands benefitting from e-commerce and a recovery in beauty channels compared to the prior year. New innovations in Prestige Beauty include Dermalogica's biolumin-c and sound sleep cocoon and Ren's zero waste packaging.

Underlying operating margin in Beauty and Personal Care was flat, with high material inflation in palm oil having a particularly high impact on gross margin, despite stepped up pricing. Brand and marketing investment was lower overall due to reductions in Europe and South East Asia where Covid-19 restrictions impacted market growth. We invested more in the US and China, and benefitted from efficiencies in advertising production costs.

Home Care

Home Care underlying sales grew 3.9%, with 3.1% from price and 0.7% from volume. In fabric care, mid-single-digit growth in fabric cleaning and low single-digit growth in fabric enhancers was led by South Asia and Latin America. We continue to see good innovation performance from dilutable laundry liquids across Latin America, under the OMO brand. Capsule and liquid formats continued to grow well, and in China OMO became the leading capsules brand in traditional retail and second largest in e-commerce. Underlying sales in home and hygiene declined mid-single-digit as we lapped strong demand for hygiene products in 2020, and overall home and hygiene continues to trade ahead of pre-pandemic levels.

Underlying operating margin in Home Care declined by 110bps. Gross margin declined as very high input cost inflation could not yet be fully recovered through stepped up pricing. Brand and marketing investment was lower, reflecting elevated spend in 2020 behind hygiene products at the peak of the pandemic.

Foods & Refreshment

Foods and Refreshment underlying sales grew 5.6%, with volume growth of 2.9% and price of 2.7%. Ice cream grew mid-single-digit, balanced across volume and price. Growth was driven by out-of-home food, with in-home ice cream flat as we lapped double-digit prior year growth. Our Magnum and Ben & Jerry's brands each grew high single-digit. Food solutions has begun to recover from channel closure in 2020, delivering double-digit growth. In-home food saw low single-digit price led growth, following elevated demand and double-digit growth in 2020. Our largest food brand Knorr grew high single-digit across in-home and out-of-home channels through innovations such as zero-salt stock cubes and Rinde Mas in Latin America, a plant-based product that extends the yield of meat dishes while adding flavour. Dressings brand Hellmann's grew double digit for the second year in succession. Our retained tea business grew double-digit.

Foods and Refreshment underlying operating margin improved by 40bps. Gross margin declined as high input cost inflation could not yet be fully recovered through increased pricing. Brand and marketing investment increased, driven by India and China, but benefitted underlying operating margin as a result of faster turnover growth.  

 

FULL YEAR OPERATIONAL REVIEW: GEOGRAPHICAL AREA

 

 

Fourth Quarter 2021

Full Year 2021

(unaudited)

Turnover

USG

UVG

UPG

Turnover

USG

UVG

UPG

Change in underlying operating margin

 

€bn

%

%

%

€bn

%

%

%

bps

Unilever

13.1

4.9

-

4.9

52.4

4.5

1.6

2.9

(10)

Asia/AMET/RUB

6.1

5.7

1.3

4.3

24.3

5.8

3.0

2.7

50

The Americas

4.4

7.2

(1.2)

8.5

16.8

5.5

0.4

5.1

(80)

Europe

2.6

(0.8)

(1.5)

0.7

11.3

0.4

0.3

0.2

(40)

 

 

Fourth Quarter 2021

Full Year 2021

(unaudited)

Turnover

USG

UVG

UPG

Turnover

USG

UVG

UPG

 

€bn

%

%

%

€bn

%

%

%

Emerging markets

7.7

6.7

0.1

6.6

30.4

6.7

2.6

4.1

Developed markets

5.4

2.2

(0.3)

2.6

22.0

1.5

0.2

1.3

North America

2.8

6.5

1.1

5.3

10.6

3.4

0.5

2.9

Latin America

1.6

8.5

(4.8)

13.9

6.2

9.0

0.1

8.9

Asia/AMET/RUB

Underlying sales grew 5.8% with 3.0% from volume and 2.7% from price. India grew double-digit with a balanced split between price and volume. Pricing and savings actions continue to be important in India as commodity prices remain elevated. China delivered double-digit volume led growth, with food solutions growing back to above 2019 levels whilst Home Care and Beauty and Personal Care also grew well. South East Asia declined low single-digit as the region was impacted by Covid-19 related restrictions throughout the year, and our Indonesian business performance was poor in a highly competitive market.

 

In Turkey, we delivered double-digit growth with high single-digit volume. In South Africa we grew mid-single-digit in volatile market conditions, weighted towards volume.

 

Underlying operating margin increased by 50bps. Gross margin declined and was offset by efficiencies in overheads and brand and marketing investment.

The Americas

Underlying sales growth in North America was 3.4%, with 2.9% from price and 0.5% from volume as we restored competitiveness through the year. Prestige Beauty, functional nutrition and food solutions all grew strongly while in-home food and hygiene declined as we lapped the high demand of 2020. On a two-year compound annual growth basis, North America underlying sales growth is 5.5%.

 

Latin America grew 9.0% with positive pricing of 8.9% and flat volume. Throughout the year we took several price increases to counter high inflation and currency devaluation. Innovations designed for consumers feeling the negative impacts of inflation have been successful. In Brazil double-digit growth was price led with a low single digit volume decline whilst in Argentina volume remained positive.

 

Underlying operating margin decreased by 80bps. Gross margin decline was partially offset by lower overall brand and marketing investment. We increased spend in North America behind high growth areas and reduced in Latin America.

Europe

Underlying sales grew 0.4% with 0.3% from volume and 0.2% from price. Foods and Refreshment volumes grew low single-digit, as out-of-home ice cream recovered alongside in-home ice cream growth. Home Care volumes declined, as we lapped high demand for hygiene products in 2020. Beauty & Personal Care in Europe declined slightly in a declining market. Pricing actions are underway across Europe with the different national retail landscapes being managed very actively.

 

Recovery in out-of-home ice cream supported mid-single-digit growth in Italy. Germany and the UK declined as we lapped high 2020 growth for in-home foods and hygiene.

 

Underlying operating margin declined 40bps, driven by gross margin, while brand and marketing investment reduced.

 

ADDITIONAL COMMENTARY ON THE FINANCIAL STATEMENTS - FULL YEAR

Finance costs and tax

Net finance costs decreased €151 million to €354 million in 2021. The decrease was driven by a lower cost of debt and a reduction in interest on tax settlements. This was partially offset by lower interest income driven by interest on tax credits in Brazil in the prior year. The interest rate on average net debt fell to 1.5% from 2.2% in the prior year.

The underlying effective tax rate was 22.6% compared with 23.0% in 2020. We saw benefits in tax settlements and other one offs, as well as the restatement of deferred tax balances for changes in tax rates. The additional impact of non-underlying tax meant that the effective tax rate was 23.1% compared with 24.6% in 2020.

Joint ventures, associates and other income from non-current investments

Net profit from joint ventures and associates was €191 million, an increase of €16 million compared to 2020. Other income from non-current investments was €91 million and relates to investments made by Unilever Ventures.

 

Earnings per share

Underlying earnings per share increased by 5.5% to €2.62, including a negative impact of 2.3% from currency. Constant underlying earnings per share increased by 7.8%. The increase was mainly driven by operating performance, lower finance costs and income from non-current investments. There was also a reduction in the average number of shares as a result of our share buyback programme, contributing 0.9%. These were partially offset by an increase in profit attributable to minority interests. Diluted earnings per share were up 9.2% at €2.32.

Free cash flow

Free cash flow was €6.4 billion in 2021, down from the €7.7 billion delivered in 2020 as capital expenditure and cash tax paid increased. We maintained enhanced working capital discipline in 2021, although the significant favourable working capital movements generated as we increased our focus on receivables in 2020 were not repeated.

Net debt

Closing net debt was €25.5 billion compared to €20.9 billion as at 31 December 2020 driven by lower free cash flow, the €3 billion share buyback executed during the year and acquisitions including Paula's Choice. Net debt to underlying EBITDA was 2.2x as at 31 December 2021 versus 1.8x in the prior year.

Pensions

Pension assets net of liabilities were in surplus of €3.0 billion at 31 December 2021 versus a surplus of €0.3 billion at the end of 2020. The increase was driven by positive investment returns on pension assets. Pension liabilities remained unchanged overall, with a decrease from higher interest rates offsetting an increase due to higher inflation.

Return on invested capital

Return on invested capital was 17.2%, compared to 18.0% in the prior year. This is due to recent acquisitions (Horlicks and Paula's Choice), and a significant currency impact resulting in increased goodwill and intangibles.

Finance and liquidity

In 2021, we issued the following bonds:

· 12th August 2021: $500 million 3NC1 fixed rate notes at 0.626% due August 2024, $850 million fixed rates notes at 1.750% due August 2031, and $650 million fixed rate notes at 2.625% due August 2051.

 

In February 2021, $1,000 million 4.250% fixed rate notes matured and were repaid. In March 2021, $400 million 2.750% fixed rate notes matured and were repaid. In July 2021, €500 million 0.000% fixed rates notes matured and were repaid.

As at 31 December 2021 Unilever had undrawn revolving 364-day bilateral credit facilities in aggregate of $7,965 million with a 364-day term out. Additional bilateral undrawn revolving 364-day credit facilities of €1,500 million were signed in December 2021.

Share buyback programme

On 3 December 2021, we announced the completion of our €3 billion share buyback programme, initiated earlier in the year. The total consideration for the repurchase of shares is recorded within other reserves and all of the 62,976,145 shares purchased in the buyback programme are held in Treasury.

COMPETITION INVESTIGATIONS

As previously disclosed, Unilever is involved in a number of ongoing investigations by national competition authorities, including those of France, Portugal and South Africa. These proceedings and investigations are at various stages and concern a variety of product markets. Where appropriate, provisions are made and contingent liabilities disclosed in relation to such matters.

Ongoing compliance with competition laws is of key importance to Unilever. It is Unilever's policy to co-operate fully with competition authorities whenever questions or issues arise. In addition, the Group continues to reinforce and enhance its internal competition law training and compliance programme on an ongoing basis.

 

NON-GAAP MEASURES

Certain discussions and analyses set out in this announcement include measures which are not defined by generally accepted accounting principles (GAAP) such as IFRS. We believe this information, along with comparable GAAP measurements, is useful to investors because it provides a basis for measuring our operating performance, ability to retire debt and invest in new business opportunities. Our management uses these financial measures, along with the most directly comparable GAAP financial measures, in evaluating our operating performance and value creation. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP. Wherever appropriate and practical, we provide reconciliations to relevant GAAP measures.

Unilever uses 'constant rate', and 'underlying' measures primarily for internal performance analysis and targeting purposes. We present certain items, percentages and movements, using constant exchange rates, which exclude the impact of fluctuations in foreign currency exchange rates. We calculate constant currency values by translating both the current and the prior period local currency amounts using the prior year average exchange rates into euro, except for the local currency of entities that operate in hyperinflationary economies. These currencies are translated into euros using the prior year closing exchange rate before the application of IAS 29. The table below shows exchange rate movements in our key markets .

 

Annual Average rate in 2021

Annual Average rate in 2020

Brazilian Real (€1 = BRL)

6.366

5.781

 

Chinese Yuan (€1 = CNY)

7.663

7.862

 

Indian Rupee (€1 = INR)

87.599

84.100

 

Indonesia Rupiah (€1 = IDR)

16983

16557

 

Philippine Peso (€1 = PHP)

58.401

56.447

 

UK Pound Sterling (€1 = GBP)

0.861

0.888

 

US Dollar (€1 = US $)

1.187

1.135

 

Underlying sales growth (USG)

Underlying sales growth (USG) refers to the increase in turnover for the period, excluding any change in turnover resulting from acquisitions, disposals, changes in currency and price growth in excess of 26% in hyperinflationary economies. Inflation of 26% per year compounded over three years is one of the key indicators within IAS 29 to assess whether an economy is deemed to be hyperinflationary. We believe this measure provides valuable additional information on the underlying sales performance of the business and is a key measure used internally. The impact of acquisitions and disposals is excluded from USG for a period of 12 calendar months from the applicable closing date. Turnover from acquired brands that are launched in countries where they were not previously sold is included in USG as such turnover is more attributable to our existing sales and distribution network than the acquisition itself. The reconciliation of changes in the GAAP measure turnover to USG is provided in notes 3 and 4.

Underlying price growth (UPG)

Underlying price growth (UPG) is part of USG and means, for the applicable period, the increase in turnover attributable to changes in prices during the period. UPG therefore excludes the impact to USG due to (i) the volume of products sold; and (ii) the composition of products sold during the period. In determining changes in price, we exclude the impact of price growth in excess of 26% per year in hyperinflationary economies as explained in USG above. The measures and the related turnover GAAP measure are set out in notes 3 and 4.

Underlying volume growth (UVG)

Underlying volume growth (UVG) is part of USG and means, for the applicable period, the increase in turnover in such period calculated as the sum of (i) the increase in turnover attributable to the volume of products sold; and (ii) the increase in turnover attributable to the composition of products sold during such period. UVG therefore excludes any

impact on USG due to changes in prices. The measures and the related turnover GAAP measure are set out in notes 3 and 4.

Non-underlying items

Several non-GAAP measures are adjusted to exclude items defined as non-underlying due to their nature and/or frequency of occurrence.

Non-underlying items within operating profit are: gains or losses on business disposals, acquisition and disposal related costs, restructuring costs, impairments and other items within operating profit classified here due to their nature and frequency.

Non-underlying items not in operating profit but within net profit are: net monetary gain/(loss) arising from hyperinflationary economies and significant and unusual items in net finance cost, share of profit/(loss) of joint ventures and associates and taxation.

Non-underlying items are: both non-underlying items within operating profit and those non-underlying items not in operating profit but within net profit.

Underlying operating profit (UOP) and underlying operating margin (UOM)

Underlying operating profit and underlying operating margin mean operating profit and operating margin before the impact of non-underlying items within operating profit. Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for making decisions about allocating resources and assessing performance of the segments. The reconciliation of operating profit to underlying operating profit is as follows:

€ million

Full Year

(unaudited)

2021

2020

Operating profit

8,702

8,303

Non-underlying items within operating profit (see note 2)

934

1,064

Underlying operating profit

9,636

9,367

Turnover

52,444

50,724

Operating margin (%)

16.6%

16.4%

Underlying operating margin (%)

18.4%

18.5%

Underlying earnings before interest, taxation, depreciation and amortisation (UEBITDA)

Underlying earnings before interest, taxation, depreciation and amortisation means operating profit before the impact of depreciation, amortisation and non-underlying items within operating profit. We use UEBITDA in assessing our leverage level, which is expressed as net debt / UEBITDA. The reconciliation of operating profit to UEBITDA is as follows:

€ million

Full Year

(unaudited)

2021

2020

Operating profit

8,702

8,303 

 

Depreciation and amortisation

1,746

2,018 

 

Non-underlying items within operating profit

934

1,064 

 

Underlying earnings before interest, taxes, depreciation and amortisation (UEBITDA)

11,382

11,385 

 

Underlying effective tax rate

The underlying effective tax rate is calculated by dividing taxation excluding the tax impact of non-underlying items by profit before tax excluding the impact of non-underlying items and share of net (profit)/loss of joint ventures and associates. This measure reflects the underlying tax rate in relation to profit before tax excluding non-underlying items before tax and share of net profit/(loss) of joint ventures and associates. Tax impact on non-underlying items within operating profit is the sum of the tax on each non-underlying item, based on the applicable country tax rates and tax treatment. This is shown in the following table:

€ million

Full Year

(unaudited)

2021

2020

Taxation

1,935

1,923

Tax impact of:

 

 

Non-underlying items within operating profit(a)

219

272

Non-underlying items not in operating profit but within net profit(a)

(41)

(146)

Taxation before tax impact of non-underlying items

2,113

2,049

Profit before taxation

8,556

7,996

Non-underlying items within operating profit before tax(a)

934

1,064

Non-underlying items not in operating profit but within net profit before tax

64

36

Share of net (profit)/loss of joint ventures and associates

(191)

(175)

Profit before tax excluding non-underlying items before tax and share of net profit/(loss) of joint ventures and associates

9,363

8,921

Underlying effective tax rate

22.6%

23.0%

(a)  See note 2.

Underlying earnings per share

Underlying earnings per share (underlying EPS) is calculated as underlying profit attributable to shareholders' equity divided by the diluted average number of ordinary shares. In calculating underlying profit attributable to shareholders' equity, net profit attributable to shareholders' equity is adjusted to eliminate the post-tax impact of non-underlying items. This measure reflects the underlying earnings for each share unit of the Group. Refer to note 6 for reconciliation of net profit attributable to shareholders' equity to underlying profit attributable to shareholders equity.

Constant underlying EPS

Constant underlying earnings per share (constant underlying EPS) is calculated as underlying profit attributable to shareholders' equity at constant exchange rates and excluding the impact of both translational hedges and price growth in excess of 26% per year in hyperinflationary economies divided by the diluted average number of ordinary shares. This measure reflects the underlying earnings for each share unit of the Group in constant exchange rates.

The reconciliation of underlying profit attributable to shareholders' equity to constant underlying earnings attributable to shareholders' equity and the calculation of constant underlying EPS is as follows:

€ million

Full Year

(unaudited)

2021

2020

Underlying profit attributable to shareholders' equity (see note 6)

6,839 

 

6,532 

 

Impact of translation from current to constant exchange rates and translational hedges

210 

 

19 

 

Impact of price growth in excess of 26% per year in hyperinflationary economies

(42) 

 

-

 

Constant underlying earnings attributable to shareholders' equity

7,007 

 

6551 

 

Diluted average number of share units (millions of units)

2,609.6 

 

2,629.8 

 

Constant underlying EPS (€)

2.68 

 

2.49 

 

 

Net debt

Net debt is a measure that provides valuable additional information on the summary presentation of the Group's net financial liabilities and is a measure in common use elsewhere. Net debt is defined as the excess of total financial liabilities, excluding trade payables and other current liabilities, over cash, cash equivalents and other current financial assets, excluding trade and other current receivables, and non-current financial asset derivatives that relate to financial liabilities.

 

The reconciliation of total financial liabilities to net debt is as follows:

€ million

As at 31 December 2021

As at 31 December 2020

(unaudited)

Total financial liabilities

(30,133) 

 

(27,305)

 

Current financial liabilities

(7,252) 

 

(4,461)

 

Non-current financial liabilities

(22,881) 

 

(22,844)

 

Cash and cash equivalents as per balance sheet

3,415 

 

5,548 

 

Cash and cash equivalents as per cash flow statement

3,387 

 

5,475 

 

Add: bank overdrafts deducted therein

106 

 

73 

 

Less: cash and cash equivalents held for sale (a)

(78)

 

-

 

Other current financial assets

1,156 

 

808 

 

Non-current financial asset derivatives that relate to financial liabilities

52 

 

21 

 

Net debt

(25,510) 

 

(20,928)

 

(a)  Cash and cash equivalents held for sale of €78m are net of bank overdraft of €12m.  

Free cash flow (FCF)

Within the Unilever Group, free cash flow (FCF) is defined as cash flow from operating activities, less income taxes paid, net capital expenditure and net interest payments. It does not represent residual cash flows entirely available for discretionary purposes; for example, the repayment of principal amounts borrowed is not deducted from FCF. FCF reflects an additional way of viewing our liquidity that we believe is useful to investors because it represents cash flows that could be used for distribution of dividends, repayment of debt or to fund our strategic initiatives, including acquisitions, if any.

The reconciliation of cash flow from operating activities to FCF is as follows:

€ million

Full Year

(unaudited)

2021

2020

Cash flow from operating activities

10,305 

 

10,933 

 

Income tax paid

(2,333) 

 

(1,875)

 

Net capital expenditure

(1,239) 

 

(932)

 

Net interest paid

(340) 

 

(455)

 

Free cash flow

6,393 

 

7,671 

 

Net cash flow (used in)/from investing activities

(3,246) 

 

(1,481)

 

Net cash flow (used in)/from financing activities

(7,099) 

 

(5,804)

 

 

Return on invested capital (ROIC)

Return on invested capital (ROIC) is a measure of the return generated on capital invested by the Group. The measure provides a guard rail for long-term value creation and encourages compounding reinvestment within the business and discipline around acquisitions with lower returns and longer payback. ROIC is calculated as underlying operating profit after tax divided by the annual average of: goodwill, intangible assets, property, plant and equipment, net assets held for sale, inventories, trade and other current receivables, and trade payables and other current liabilities.

€ million

Full Year

(unaudited)

2021

2020

Operating profit

8,702

8,303

Non-underlying items within operating profit (see note 2)

934

1,064

Underlying operating profit before tax

9,636

9,367

Tax on underlying operating profit(a)

(2,175)

(2,154)

Underlying operating profit after tax

7,461

7,213

Goodwill

20,330

18,942

Intangible assets

18,261

15,999

Property, plant and equipment

10,347

10,558

Net assets held for sale

1,581

27

Inventories

4,683

4,462

Trade and other current receivables

5,422

4,939

Trade payables and other current liabilities

(14,861)

(14,132)

Period-end invested capital

45,763

40,795

Average invested capital for the period

43,279

40,029

Return on invested capital

17.2%

18.0%

(a)  Tax on underlying operating profit is calculated as underlying operating profit before tax multiplied by the underlying effective tax rate of 22.6% (2020: 23.0%) which is shown on page 9.

 

  CAUTIONARY STATEMENT

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2020 and the Unilever Annual Report and Accounts 2020.

 

  ENQUIRIES

 

Media : Media Relations Team

Investors: Investor Relations Team

UK

«44 78 2527 3767

[email protected]

«44 20 7822 6830

[email protected]

or

«44 77 7999 9683

[email protected]

 

 

NL

«31 10 217 4844

[email protected]

 

 

or

«31 62 375 8385

[email protected]

 

 

There will be a web cast of the results presentation available at:

www.unilever.com/investor-relations/results-and-presentations/latest-results

 

  INCOME STATEMENT

(unaudited)

€ million

Full Year

 

2021

2020

Increase/

(Decrease)

Current

rates

Constant

rates

 

 

 

 

 

Turnover

52,444

50,724

3.4%

6.2%

 

 

 

 

 

 Operating profit

8,702

8,303

4.8%

9.6%

 

 

 

 

 

Which includes non-underlying items credits/(charges) of

(934)

(1,064)

 

 

 

 

 

 

 

Net finance costs

(354)

(505)

 

 

Pensions and similar obligations

 

(10)

(9)

 

 

Finance income

147

232

 

 

Finance costs

(491)

(728)

 

 

 

 

 

 

 

Which includes non-underlying income/(costs) of

10

(56)

 

 

 

 

 

 

 

Non-underlying item net monetary gain/(loss) arising from

 

 

 

 

hyperinflationary economies

(74)

20

 

 

 

 

 

 

 

Share of net profit/(loss) of joint ventures and associates

191

175

 

 

Other income/(loss) from non-current investments and associates

91

3

 

 

 

 

 

 

 

Profit before taxation

8,556

7,996

7.0%

12.9%

 

 

 

 

 

Taxation

(1,935)

(1,923)

 

 

Which includes tax impact of non-underlying items of

178

126

 

 

 

 

 

 

 

Net profit

6,621

6,073

9.0%

16.0%

 

 

 

 

 

Attributable to:

 

 

 

 

Non-controlling interests

572

492

 

 

Shareholders' equity

6,049

5,581

8.4%

15.4%

 

Combined earnings per share

 

 

 

 

 Basic earnings per share (euros)

2.33

2.13

9.2%

16.3%

 Diluted earnings per share (euros)

2.32

2.12

9.2%

16.3%

 

STATEMENT OF COMPREHENSIVE INCOME

(unaudited)

 

€ million

Full Year

 

2021

2020

 

 

 

 Net profit

6,621

6,073

 

 

 

 Other comprehensive income

 

 

 Items that will not be reclassified to profit or loss, net of tax:

 

 

Gains/(losses) on equity instruments measured at fair value through other comprehensive income

166

78

Remeasurement of defined benefit pension plans

1,734

215

  Items that may be reclassified subsequently to profit or loss, net of tax:

 

 

  Gains/(losses) on cash flow hedges

279

60

Currency retranslation gains/(losses)

1,177

(2,590)

 

 

 

 Total comprehensive income

9,977

3,836

 

 

 

 Attributable to:

 

 

 Non-controlling interests

749

286

 Shareholders' equity

9,228

3,550

 

  STATEMENT OF CHANGES IN EQUITY

(unaudited)

 

€ million

Called up share capital

Share premium account

Unification reserve

Other reserves

Retained profit

Total

Non- controlling interest

Total equity

31 December 2019

420

134

-

(5,574)

18,212

13,192

694

13,886

Profit or loss for the period

-

-

-

-

5,581

5,581

492

6,073

Other comprehensive income, net of tax:

 

 

 

 

 

 

 

 

Gains/(losses) on:

 

 

 

 

 

 

 

 

Equity instruments

-

-

-

68

-

68

10

78

Cash flow hedges

-

-

-

62

-

62

(2)

60

Remeasurements of defined benefit pension plans

-

-

-

-

217

217

(2)

215

Currency retranslation gains/(losses)

-

-

-

(2,356)

(22)

(2,378)

(212)

(2,590)

Total comprehensive income

-

-

-

(2,226)

5,776

3,550

286

3,836

Dividends on ordinary capital

-

-

-

-

(4,300)

(4,300)

-

(4,300)

Issue of PLC ordinary shares as part of Unification(a)

51

-

-

-

(51)

-

-

-

Cancellation of NV ordinary shares as part of Unification(a)

(233)

(20)

-

-

253

-

-

-

Other effects of Unification(b)

(146)

73,364

(73, 364)

132

14

-

-

-

Movements in treasury shares(c)

-

-

-

220

(158)

62

-

62

Share-based payment credit(d)

-

-

-

-

108

108

-

108

Dividends paid to non-controlling interests

-

-

-

-

-

-

(559)

(559)

Currency retranslation gains/(losses) net of tax

-

(6)

-

-

-

(6)

-

(6)

Hedging gain/(loss) transferred to non-financial assets

-

-

-

10

-

10

2

12

Net gain arising from Horlicks acquisition(e)

-

-

-

-

2,930

2,930

1,918

4,848

Other movements in equity(f)

-

-

-

(44)

(236)

(280)

48

(232)

31 December 2020

92

73,472

(73,364)

(7,482)

22,548

15,266

2,389

17,655

Profit or loss for the period

-

-

-

-

6,049

6,049

572

6,621

Other comprehensive income, net of tax:

 

 

 

 

 

 

 

 

Gains/(losses) on:

 

 

 

 

 

 

 

 

Equity instruments

-

-

-

147

-

147

19

166

Cash flow hedges

-

-

-

276

-

276

3

279

Remeasurements of defined benefit pension plans

-

-

-

-

1,728

1,728

6

1,734

Currency retranslation gains/(losses)

-

-

-

1,025

3

1,028

149

1,177

Total comprehensive income

-

-

-

1,448

7,780

9,228

749

9,977

Dividends on ordinary capital

-

-

-

-

(4,458)

(4,458)

-

(4,458)

Share capital reduction(g)

-

(20,626)

-

-

20,626

-

-

-

Repurchase of shares(h)

-

-

-

(3,018)

-

(3,018)

-

(3,018)

Movements in treasury shares(c)

-

-

-

95

(143)

(48)

-

(48)

Share-based payment credit(d)

-

-

-

-

161

161

-

161

Dividends paid to non-controlling interests

-

-

-

-

-

-

(503)

(503)

Hedging gain/(loss) transferred to non-financial assets

-

-

-

(171)

-

(171)

(3)

(174)

Other movements in equity(f)

-

(2)

-

(82)

231

147

7

154

31 December 2021

92

52,844

(73,364)

(9,210)

46,745

17,107

2,639

19,746

a)  As part of Unification, NV shareholders were issued new PLC shares, all issued NV shares were cancelled. The impact is recognised in retained profit.

b)  Includes the reduction of PLC's share capital following the cessation of the Equalisation Agreement. Prior to Unification, a conversion rate of £1= 5.143 was used in accordance with the Equalisation Agreement to translate PLC's share capital. Following Unification, PLC's share capital has been translated using the exchange rate at the date of Unification. To reflect the legal share capital of the PLC company, an increase to share premium of €73,364 million and a debit to the unification reserve for the same amount have been recorded as there is no change in the net assets of the group. This debit is not a loss as a matter of law.

c)  Includes purchases and sales of treasury shares, other than the share buyback programme and the transfer from treasury shares to retained profit of share-settled schemes arising from prior years and differences between exercise and grant price of share options in 2020.

d)  The share-based payment credit relates to the non-cash charge recorded against operating profit in respect of the fair value of share options and awards granted to employees.

e)  Consideration for the Horlicks Acquisition included the issuance of shares in a group subsidiary, Hindustan Unilever Limited, which resulted in a net gain being recognised within equity.

f)  2021 includes a hyperinflation adjustment of € 280 million and €82 million related to the Welly acquisition.   2020 includes €163 million paid for purchase of the non-controlling interest in Unilever Malaysia .

g)  Share premium has been adjusted to reflect the legal share capital of the PLC company, which reduced by £18,400 million following court approval on 15 June 2021.

h)  Repurchase of shares reflects the cost of acquiring ordinary shares as part of the share buyback program announced on 29 April 2021.

 

  BALANCE SHEET

 

(unaudited)

€ million

As at 31 December 2021

As at 31 December 2020

 

Non-current assets

 

 

Goodwill

20,330 

18,942 

 

Intangible assets

18,261 

15,999 

 

Property, plant and equipment

10,347 

10,558 

 

Pension asset for funded schemes in surplus

5,119 

2,722 

 

Deferred tax assets

1,465 

1,474 

 

Financial assets

1,198 

876 

 

Other non-current assets

974 

931 

 

 

57,694 

51,502 

 

Current assets

 

 

Inventories

4,683 

4,462 

 

Trade and other current receivables

5,422 

4,939 

 

Current tax assets

324 

372 

 

Cash and cash equivalents

3,415 

5,548 

 

Other financial assets

1,156 

808 

 

Assets held for sale

2,401 

28 

 

 

17,401 

16,157 

 

 

 

 

Total assets

75,095

67,659 

 

 

 

 

Current liabilities

 

 

Financial liabilities

7,252 

4,461 

 

Trade payables and other current liabilities

14,861 

14,132 

 

Current tax liabilities

1,365 

1,451 

 

Provisions

480 

547 

 

Liabilities held for sale

820 

 

 

24,778 

20,592 

 

Non-current liabilities

 

 

Financial liabilities

22,881 

22,844 

 

Non-current tax liabilities

148 

149 

 

Pensions and post-retirement healthcare liabilities:

 

 

Funded schemes in deficit

831 

1,109 

 

Unfunded schemes

1,295 

1,326 

 

Provisions

611 

583 

 

Deferred tax liabilities

4,530 

3,166 

 

Other non-current liabilities

275 

235 

 

 

30,571 

29,412 

 

 

 

 

Total liabilities

55,349

50,004 

 

Equity

 

 

Shareholders' equity

17,107 

15,266 

 

Non-controlling interests

2,639 

2,389 

 

Total equity

19,746 

17,655 

 

 

 

 

Total liabilities and equity

75,095 

67,659 

 

 

CASH FLOW STATEMENT

(unaudited)

€ million

Full Year

 

2021

2020

 

 

 

Net profit

6,621

6,073 

 

Taxation

1,935

1,923 

 

Share of net (profit)/loss of joint ventures/associates and other (income)/loss from non-current investments and associates

(282)

 

(178)

 

Net monetary (gain)/loss arising from hyperinflationary economies

74

(20)

 

Net finance costs

354

505 

 

Operating profit

8,702

8,303 

 

Depreciation, amortisation and impairment

  1,763

 

2,018 

 

Changes in working capital

(47)

680 

 

Pensions and similar obligations less payments

(183)

(182)

 

Provisions less payments

(61)

(53)

 

Elimination of (profits)/losses on disposals

23

60 

 

Non-cash charge for share-based compensation

161

108 

 

Other adjustments

(53)

(1)

 

Cash flow from operating activities

10,305

10,933 

 

Income tax paid

(2,333)

(1,875)

 

Net cash flow from operating activities

7,972

9,058 

 

Interest received

148

 

169 

 

Net capital expenditure

(1,239)

(932)

 

Acquisitions and disposals

(2,088)

(1,387)

 

Other investing activities

(67)

669 

 

 

 

 

Net cash flow (used in)/from investing activities

(3,246)

(1,481)

 

Dividends paid on ordinary share capital

(4,483)

 

(4,279)

 

Interest paid

(488)

(624)

 

Change in financial liabilities

1,390

(181)

 

Repurchase of shares

(3,018)

-  

 

Other financing activities

(500)

(720)

 

Net cash flow (used in)/from financing activities

(7,099)

(5,084)

 

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

(2,373)

1,773 

 

 

 

 

Cash and cash equivalents at the beginning of the period

5,475

4,116 

 

 

 

 

Effect of foreign exchange rate changes

285

(414)

 

 

 

 

Cash and cash equivalents at the end of the period

3,387

5,475 

 

 

  NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(unaudited)

 

1  ACCOUNTING INFORMATION AND POLICIES

Except as set out below the accounting policies and methods of computation are consistent with the year ended 31 December 2020. In conformity with the requirements of the Companies Act 2006 , the condensed preliminary financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and as adopted for use in the UK.

 

The condensed financial statements are shown at current exchange rates, while percentage year-on-year changes are shown at both current and constant exchange rates to facilitate comparison. The income statement on page 13, the statement of comprehensive income on page 13, the statement of changes in equity on page 14 and the cash flow statement on page 16 are translated at exchange rates current in each period. The balance sheet on page 15 is translated at period-end rates of exchange.  

On 29 November 2020, the Unilever Group underwent a reorganisation so that there were no longer two parent companies, Unilever N.V. ('NV') and Unilever PLC ('PLC'), but one parent company PLC.  This reorganisation is referred to as 'Unification' in the condensed financial statements. Prior to Unification, NV and PLC together with the group companies operated as a single economic entity. Following Unification, all group companies are now controlled solely by PLC. All companies controlled by NV before Unification are included in the group consolidation for the year ending 31 December 2020 and they were already group companies prior to Unification.   The only impact to the consolidated balance sheet from Unification is within equity due to the cancellation of NV shares and issuance of PLC shares in 2020.

The condensed financial statements attached do not constitute the full financial statements within the meaning of Section 434 of the UK Companies Act 2006, which will be finalised and delivered to the Registrar of Companies in due course. Full accounts for Unilever for the year ended 31 December 2020 have been delivered to the Registrar of Companies; the auditors' reports on these accounts were unqualified, did not include a reference to any matters by way of emphasis and did not contain a statement under Section 498 (2) or Section 498 (3) of the UK Companies Act 2006.  

ORMATION AND POLICIES   1 ACCOUNTING INFORMATION AND POLICIES (continued)  

New accounting standards  

 

Interest Rate Benchmark Reform (Phase 2) Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (effective 1 January 2022)

The Group has adopted the amendments that allow modifications to asset and liability values as a direct consequence of the interest rate benchmark reform, and which are made on an economically equivalent basis (i.e. where the basis for determining contractual cash flows is the same), can be accounted for by only updating the effective interest rate. The Group does not have significant financial instruments that refer to an interest rate benchmark so these amendments do not have a material impact on Unilever.

 

2  SIGNIFICANT ITEMS WITHIN THE INCOME STATEMENT

Non-underlying items

These include non-underlying items within operating profit and non-underlying items not in operating profit but within net profit:

· Non-underlying items within operating profit are gains or losses on business disposals, acquisition and disposal related costs, restructuring costs, impairment and other items within operating profit classified here due to their nature and frequency.

· Non-underlying items not in operating profit but within net profit are net monetary gain/(loss) arising from hyperinflationary economies and significant and unusual items in net finance cost, share of profit/(loss) of joint ventures and associates and taxation.

 

Restructuring costs are charges associated with activities planned by management that significantly change either the scope of the business or the manner in which it is conducted.

€ million

Full Year

 

2021

2020

Acquisition and disposal-related credits/(costs) (a)

(332)

(69)

 

Gain/(loss) on disposal of group companies(b)

36

 

Restructuring costs(c)

(632)

(916)

 

Impairments(d)

(17)

-  

 

Other(e)

11

(87)

 

Non-underlying items within operating profit before tax

(934)

(1,064)

 

 

 

 

Tax on non-underlying items within operating profit

219

272 

 

Non-underlying items within operating profit after tax

(715)

(792)

 

 

 

 

Interest related to the UK tax audit of intangible income and centralised services

10

(56)

 

Net monetary gain/(loss) arising from hyperinflationary economies

(74)

20 

 

Non-underlying items not in operating profit but within net profit before tax

(64)

(36)

 

 

 

 

Tax impact of non-underlying items not in operating profit but within net profit:

 

 

Taxes related to share buyback as part of Unification

-

(30)

 

Taxes related to the UK tax audit of intangible income and centralised services

(29)

(53)

 

Taxes related to the reorganisation of our European business

31

(58)

 

Hyperinflation adjustment for Argentina deferred tax

(43)

(5)

 

Non-underlying items not in operating profit but within net profit after tax

(105)

(182)

 

 

 

 

Non-underlying items after tax(f)

(820)

(974)

 

 

 

 

Attributable to:

 

 

Non-controlling interests

(30)

(23)

 

Shareholders' equity

(790)

(951)

 

(a)  2021 includes a charge of €196m relating to the disposal of ekaterra and other acquisition and disposal activities.

(b)  2021 gain relates to several small disposals of brands in Foods and Refreshment. The 2020 gain relates to the disposal of a laundry bar business in Latin America.

(c)  Restructuring costs are comprised of various supply chain optimisation projects and organisational change programmes across markets.

(d)  Relates to the write down of leased land and building assets.

(e)  2020 includes a charge of €87 million for litigation matters in relation to investigations by national competition authorities including those in Turkey and France.

(f)  Non-underlying items after tax is calculated as non-underlying items within operating profit after tax plus non-underlying items not in operating profit but within net profit after tax.

 

  SEGMENT INFORMATION - DIVISIONS

 

Fourth Quarter

Beauty &

Personal

Care

Home

Care

Foods & Refreshment

Total

Turnover (€ million)

 

 

 

 

2020

5,176

2,547

4,379

12,102

2021

5,769

  2,729

4,623

13,121

Change (%)

11.5

7.1

5.6

8.4

Impact of:

 

 

 

 

Acquisitions (%)

2.4

0.1

-

1.1

Disposals (%)

-

-

(0.3)

(0.1)

Currency-related items (%), of which:

2.5

2.0

2.5

2.4

Exchange rates changes (%)

2.1

1.5

2.0

1.9

Extreme price growth in hyperinflationary markets* (%)

0.4

0.5

0.5

0.4

Underlying sales growth (%)

6.2

5.0

3.2

4.9

Price* (%)

5.3

8.4

2.5

4.9

Volume (%)

0.9

(3.1)

0.6

-

 

Full Year

Beauty &

Personal

Care

Home

Care

Foods & Refreshment

Total

Turnover (€ million)

 

 

 

 

2020

21,124

 

10,460

 

19,140

 

50,724

 

2021

  21,901

10,572

19,971

52,444

Change (%)

3.7

1.1

4.3

3.4

Impact of:

 

 

 

 

Acquisitions (%)

2.7

-

0.8

1.4

Disposals (%)

-

(0.1)

(0.2)

(0.1)

Currency-related items (%), of which:

(2.8)

(2.6)

(1.8)

(2.4)

Exchange rate changes (%)

(3.0)

(2.9)

(2.1)

(2.6)

Extreme price growth in hyperinflationary markets* (%)

0.2

0.3

0.3

0.3

Underlying sales growth (%)

3.8

3.9

5.6

4.5

Price* (%)

3.0

3.1

2.7

2.9

Volume (%)

0.8

0.7

2.9

1.6

 

 

 

 

 

Operating profit (€ million)

 

 

 

 

2020

4,311 

 

1,243 

 

2,749 

 

8,303 

 

2021

4,471

1,294

2,937

8,702

Underlying operating profit (€ million)

 

 

 

 

2020

4,591 

 

1,519 

 

3,257 

 

9,367 

 

2021

4,742

1,417

3,477

9,636

Operating margin (%)

 

 

 

 

2020

20.4 

 

11.9 

 

14.4 

 

16.4 

 

2021

20.4

12.2

14.7

16.6

Underlying operating margin (%)

 

 

 

 

2020

21.7 

 

14.5 

 

17.0 

 

18.5 

 

2021

21.7

13.4

17.4

18.4

*Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.

 

Turnover growth is made up of distinct individual growth components namely underlying sales, currency impact, acquisitions and disposals. Turnover growth is arrived at by multiplying these individual components on a compounded basis as there is a currency impact on each of the other components. Accordingly, turnover growth is more than just the sum of the individual components.

Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for the purpose of making decisions about allocating resources and assessing performance of segments. Underlying operating margin is calculated as underlying operating profit divided by turnover.

 

4  SEGMENT INFORMATION - GEOGRAPHICAL AREA

 

  Fourth Quarter

Asia /

AMET /

RUB

The

Americas

Europe

Total

 
 
 

 

 

 

 

 

 

Turnover (€ million)

 

 

 

 

 

2020

5,649 

 

3,884 

 

2,569 

 

12,102 

 

 

2021

6,131

4,382

2,608

13,121

 

Change (%)

8.5

12.8

1.5

8.4

 

Impact of:

 

 

 

 

 

Acquisitions (%)

0.2

2.4

0.9

1.1

 

Disposals (%)

-

-

(0.4)

(0.1)

 

Currency-related items (%), of which:

2.5

2.8

1.8

2.4

 

Exchange rates changes (%)

2.4

1.6

1.8

1.9

 

Extreme price growth in hyperinflationary markets* (%)

0.1

1.2

-

0.4

 

Underlying sales growth (%)

5.7

7.2

(0.8)

4.9

 

Price* (%)

4.3

8.5

0.7

4.9

 

Volume (%)

1.3

(1.2)

(1.5)

(0.0)

 
                 

 

 

Full Year

Asia /

AMET /

RUB

The

Americas

Europe

Total

 
 
 

 

 

 

 

 

 

Turnover (€ million)

 

 

 

 

 

2020

23,440 

 

16,080 

 

11,204 

 

50,724 

 

 

2021

24,264

16,844

11,336

52,444

 

Change (%)

3.5

4.8

1.2

3.4

 

Impact of:

 

 

 

 

 

Acquisitions (%)

0.8

3.2

0.3

1.4

 

Disposals (%)

-

(0.1)

(0.3)

(0.1)

 

Currency- related items (%), of which:

(2.9)

(3.6)

0.7

(2.4)

 

Exchange rates changes (%)

(3.0)

(4.3)

0.7

(2.6)

 

Extreme price growth in hyperinflationary markets* (%)

0.1

0.8

-

0.3

 

Underlying sales growth (%)

5.8

5.5

0.4

4.5

 

Price* (%)

2.7

5.1

0.2

2.9

 

Volume (%)

3.0

0.4

0.3

1.6

 

 

 

 

 

 

 

Operating profit (€ million)

 

 

 

 

 

2020

4,137 

 

2,723 

 

1,443 

 

8,303 

 

 

2021

4,536

2,696

1,470

8,702

 

Underlying operating profit (€ million)

 

 

 

 

 

2020

4,546 

 

2,973 

 

1,848 

 

9,367 

 

 

2021

4,833

2,980

1,823

9,636

 

Operating margin (%)

 

 

 

 

 

2020

17.6 

 

16.9 

 

12.9 

 

16.4 

 

 

2021

18.7

16.0

13.0

16.6

 

Underlying operating margin (%)

 

 

 

 

 

2020

19.4 

 

18.5 

 

16.5 

 

18.5 

 

 

2021

19.9

17.7

16.1

18.4

 

*Underlying price growth in excess of 26% per year in hyperinflationary economies has been excluded when calculating the price growth in the tables above, and an equal and opposite amount is shown as extreme price growth in hyperinflationary markets.

5  TAXATION

The effective tax rate for 2021 is 23.1% compared to 24.6% in 2020. The decrease is primarily driven by tax on one-off items in 2020 including the tax impact of certain non-underlying items .

Tax effects of components of other comprehensive income were as follows:

€ million

Full Year 2021

Full Year 2020

 

 

 

Before

tax

Tax

(charge)/

credit

After

tax

Before

tax

Tax

(charge)/

credit

After

tax

 

 

 

 

 

 

Gains/(losses) on:

 

 

 

 

 

 

 

 

Equity instruments at fair value through other comprehensive income

178

(12)

166

77 

 

 

78 

 

 

 

Cash flow hedges

291

(12)

279

87 

 

(27)

 

60 

 

 

 

Remeasurements of defined benefit pension plans

2,405

(671)

1,734

250 

 

(35)

 

215 

 

 

 

Currency retranslation gains/(losses)

1,237

(60)

1,177

(2,646)

 

56 

 

(2,590)

 

 

 

Other comprehensive income

4,111

(755)

3,356

(2,232)

 

(5)

 

(2,237)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6  COMBINED EARNINGS PER SHARE

 
                       

 

The combined earnings per share calculations are based on the average number of share units representing the combined ordinary shares of NV and PLC in issue during the period, less the average number of shares held as treasury shares.

In calculating diluted earnings per share and underlying earnings per share, a number of adjustments are made to the number of shares, principally the exercise of share plans by employees.

Earnings per share for total operations for the twelve months were calculated as follows:

 

2021

2020

Combined EPS - Basic

 

 

Net profit attributable to shareholders' equity (€ million)

6,049

5,581 

 

Average number of shares (millions of share units) (a)

2,599.9

2,620.3 

 

Combined EPS - basic (€)

2.33

2.13 

 

 

Combined EPS - Diluted

 

 

Net profit attributable to shareholders' equity (€ million)

6,049

5,581 

 

Adjusted average number of shares (millions of share units)(a)

2,609.6

2,629.8 

 

Combined EPS - diluted (€)

2.32

2.12 

 

 

Underlying EPS

 

 

Net profit attributable to shareholders' equity (€ million)

6,049

5,581 

 

Post tax impact of non-underlying items attributable to shareholders' equity (see note 2)

790

951 

 

Underlying profit attributable to shareholders' equity

6,839

6,532 

 

Adjusted average number of shares (millions of share units)(a)

2609.6

2,629.8 

 

Underlying EPS - diluted (€)

2.62

2.48 

 

(a)  In the calculation of the weighted average number of share units, NV shares are included only for the period they were issued, until 29 November 2020. Following Unification (see note 1 for more information on Unification), all NV shares were cancelled and the shareholders of NV were issued PLC ordinary shares on a 1:1 ratio. Accordingly, there is no significant impact on the calculation of average number of share units.

In calculating underlying earnings per share, net profit attributable to shareholders' equity is adjusted to eliminate the post-tax impact of non-underlying items.

During the period the following movements in shares have taken place:

 

Millio ns

Number of shares at 31 December 2020 (net of treasury shares)

2,622.0 

 

Net movements in shares under incentive schemes

2.0

Shares repurchased under the share buyback programme

-63.0

Number of shares at 31 December 2021

2,561.0

 

7  ACQUISITIONS AND DISPOSALS

In 2021, the Group completed the business acquisitions listed below. The total consideration for acquisitions in 2021 is €2,117 million (2020: €6,337 million for acquisitions completed during that year). Total consideration for 2021 disposals is €49 million (2020: €35 million for disposals completed during that year).

On 18 November 2021, the Group announced that it has entered into an agreement to sell its global Tea business (ekaterra) to CVC Capital Partners Fund VIII for €4.5 billion on a cash-free, debt-free basis with completion expected in the second half of 2022. 

 

Deal completion date

Acquired/Disposed business

29 January 2021

Acquired 51% of Welly Health, a producer of bandages and other healthcare related items. The acquisition helps to expand our existing Health and Wellbeing portfolio.

28 May 2021

Acquired Onnit Lab Inc., a holistic wellness and lifestyle company based in the US. The acquisition complements our growing portfolio of innovative wellness and supplement brands.

2 August 2021

Acquired Paula's Choice Inc., a Prestige Skin Care company based in the U.S. The acquisition strengthens our presence in Prestige Beauty, with an established direct to consumer e-commerce business.

 

Paula's Choice Acquisition

On 2 August 2021, the Group acquired 100% of the shares of Paula's Choice Inc., a U.S. based Prestige Skin Care company. The total consideration paid was € 1,832 million which comprised of €1,818 million cash paid on the completion date and €14 million of deferred consideration. The provisional fair value of net assets recognised on the balance sheet is €1,223 million. Currently all balances remain provisional as we finalise our review of the asset valuations. As part of the acquisition, goodwill of €609 million has been recognized and which is not deductible for tax purposes Since the acquisition date, the goodwill balance has increased by €37 million as a result of foreign exchange effects.

Impact of all acquisitions

Effect on consolidated income statement

The acquisition deals completed in 2021 have contributed €196 million to Group turnover and €16 million to Group operating profit since the relevant acquisition dates. If the acquisition deals completed in 2021 had all taken place at the beginning of the year, Group turnover would have been €52,637 million and Group operating profit would have been €8,738 million.

Effect on consolidated balance sheet

The following table summarises the consideration and net assets acquired for the Paula's Choice acquisition and other acquisitions. The fair value currently used for the opening balance of the Paula's Choice acquisition is provisional. These balances remain provisional due to outstanding relevant information about the facts and circumstances that existed as of the acquisition date and/or where valuation work is still ongoing.

 

 

Paula's Choice

€ million

Other

acquisitions

€ million

Total

2021

€ million

Intangible assets

1,584

 

160

 

 

1,744

 

Other non-current assets

4

 

4

 

8

 

Trade and other receivables

15

 

 

 

6

 

21

 

Other current assets(a)

48

 

35

 

83

 

Non-current liabilities(b)

(385)

 

(43)

 

(428)

 

Current liabilities (c)

(43)

 

(13)

 

(56)

 

Net assets acquired

1,223

 

149

 

1,372

 

Non-controlling interest

 

 

(14)

 

(14)

 

Goodwill

609

 

150

 

759

 

Total consideration

1,832

 

285

 

2,117

 

Of which:

 

 

 

Cash consideration paid

1,818

 

270

 

2,088

 

Deferred consideration

14

 

15

 

29

 

(a)  Other current assets include inventories of €29 million and cash of €17 million in Paula's Choice, with the remaining €35 million split between cash of €14 million and inventories of €13 million in Onnit.

(b)  Non-current liabilities include deferred tax of €384 million related to Paula's Choice.

(c)  Current liabilities include trade and other payable of €36 million in Paula's Choice.

 

8  SHARE-BUY BACK

On 29 April 2021 we announced a share buyback programme of up to €3 billion, which was completed on 3 December 2021. The Group has repurchased 62,976,145 ordinary shares as part of the programme which are held by Unilever as treasury shares. Consideration paid for the repurchase of shares including  transaction costs was €3,018 million which is recorded within other reserves.

9  FINANCIAL INSTRUMENTS

The Group's Treasury team aims to protect the Group's financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2021 and 2020. The Group's cash resources and other financial assets are shown below.

 

€ million

31 December 2021

31 December 2020

Current

Non-current

Total

Current

Non-current

Total

Cash and cash equivalents

 

 

 

 

 

 

Cash at bank and in hand

2,505

-

2,505

2,764

-

2,764

Short-term deposits(a)

811

-

811

2,764

-

2,764

Other cash equivalents

99

-

99

20

-

20

 

3,415

-

3,415

5,548

-

5,548

 

 

 

 

 

 

 

Other financial assets

 

 

 

 

 

 

Financial assets at amortised cost(b)

750

208

958

468

138

606

Financial assets at fair value through other comprehensive income(c)

1

526

527

9

361

370

Financial assets at fair value through profit or loss:

 

 

 

 

 

 

Derivatives

76

52

128

59

21

80

Other(d)

329

412

741

272

356

628

 

1,156

1,198

2,354

808

876

1,684

Total financial assets(e)

4,571

1,198

5,769

6,356

876

7,232

(a)  Short-term deposits typically have maturity of up to 3 months.

(b)  Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months excluding deposits which are part of a recognised cash management process and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposits of €157 million (2020: €101 million).

(c)  Included within non-current financial assets at fair value through other comprehensive income are equity investments of €521 million (2020: €356 million)

(d)  Included within current financial assets at fair value through profit or loss are highly liquid debt mutual funds. Included within non-current financial assets at fair value through profit or loss are assets in a trust to fund benefit obligations in the US, an option over a non-controlling interest in a subsidiary in Hong Kong and investments in a number of companies and financial institutions in North America, North Asia, South Asia and Europe.

(e)  Financial assets exclude trade and other current receivables.

The Group is exposed to the risks of changes in fair value of its financial assets and liabilities. The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category.

€ million

Fair value

Carrying amount

As at 31 December 2021

As at 31 December 2020

As at 31 December 2021

As at 31 December 2020

Financial assets

 

 

 

 

Cash and cash equivalents

3,415

5,548 

3,415

5,548 

Financial assets at amortised cost

958

606 

958

606 

Financial assets at fair value through other comprehensive income

527

370 

527

370 

Financial assets at fair value through profit and loss:

 

 

 

 

Derivatives

128

80 

128

80 

Other

741

628 

741

628 

 

5,769

7,232 

5,769

7,232 

Financial liabilities

 

 

 

 

Bank loans and overdrafts

(402)

(411)

(402)

(411)

Bonds and other loans

(29,133)

(26,936)

(27,621)

(24,585)

Lease liabilities

(1,649)

(1,771)

(1,649)

(1,771)

Derivatives

(184)

(315)

(184)

(315)

Other financial liabilities

(277)

(223)

(277)

(223)

(31,645)

(29,656)

(30,133)

(27,305)

 

€ million

Level 1

Level 2

Level 3

Level 1

Level 2

Level 3

 

As at 31 December 2021

As at 31 December 2020

Assets at fair value

 

 

 

 

 

 

Financial assets at fair value through other comprehensive income

6

3

518

 

 

362 

 

Financial assets at fair value through profit or loss:

 

 

 

 

 

 

Derivatives(a)

-

289

-

 

158 

 

 

Other

331

-

410

300 

 

 

328 

 

Liabilities at fair value

 

 

 

 

 

 

Derivatives(b)

-

(235)

-

 

(418)

 

 

Contingent consideration

-

-

(180)

 

 

(140)

 

(a)  Includes €161 million ( 2020 : €78 million) derivatives, reported within trade receivables, that hedge trading activities .

(b)  Includes €(51) million ( 2020 : €(103) million) derivatives, reported within trade creditors, that hedge trading activities.

There were no significant changes in classification of fair value of financial assets and financial liabilities since 31 December 2020. There were also no significant movements between the fair value hierarchy classifications since 31 December 2020.

The fair value of trade receivables and payables is considered to be equal to the carrying amount of these items due to their short-term nature.

Calculation of fair values

The fair values of the financial assets and liabilities are defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Methods and assumptions used to estimate the fair values are consistent with those used in the year ended 31 December 2020.

10  ASSETS HELD FOR SALE

 

On 18 November 2021, Unilever announced that it has entered into an agreement to sell its global Tea business (ekaterra) to CVC Capital Partners Fund VIII for €4.5 billion on a cash-free, debt-free basis, with completion expected in the second half of 2022.  As a result, the assets and liabilities of ekaterra have been classified as held for sale as at 31 December 2021. Following classification as held for sale, these assets and liabilities are recognised as current on the balance sheet.

 

 

2021

ekaterra

2021

Others (a)

2021

Total

2020

Total

 
 
 

Property, plant and equipment held for sale (b)

 

2

2

17

 

 

 

 

 

 

 

 

 

 

 

Non-Current assets

 

 

 

 

 

 

 

 

 

 

 

Goodwill and intangible assets

899

2

901

1

 

Property, plant and equipment

425

22

447

4

 

Deferred tax assets

329

-

329

-

 

Other non-current assets

25

-

25

-

 

 

1,678

24

1,702

5

 

Current assets

 

 

 

 

 

Inventories

258

-

258

6

 

Trade and other receivables

336

-

336

-

 

Current tax assets

11

-

11

-

 

Cash and cash equivalents

90

-

90

-

 

Other current assets

2

-

2

-

 

 

697

-

697

6

 

Assets held for sale

2,375

26

2,401

28

 

Current liabilities

 

 

 

 

 

Trade payables and other current liabilities

652

-

652

1

 

Current tax liabilities

9

-

9

-

 

Financial liabilities

49

-

49

-

 

Provisions

8

-

8

-

 

 

718

-

718

1

 

Non-Current liabilities

 

 

 

 

 

Pensions and post-retirement healthcare liabilities

12

-

12

-

 

Financial Liabilities

31

-

31

-

 

Other non-current liabilities

2

-

2

-

 

Deferred tax liabilities

57

-

57

-

 

 

102

-

102

-

 

Liabilities held for sale

820

-

820

1

 
                 

 

(a)  In 2021, other disposal groups include assets related to the disposal of the Calve and Baltimore brands in Russia. We reversed the held for sale position of a number of small Beauty and Personal Care brands in the second half of 2021.

(b)  In 2020, disposal groups held for sale related to manufacturing assets.

11  DIVIDENDS AND SHARE BUYBACKS

The Board has declared a quarterly interim dividend for Q4 2021 of   £0.3602 per Unilever PLC ordinary share or €0.4268 per Unilever PLC ordinary share at the applicable exchange rate issued by WM/Reuters on 8 February 2022.

The following amounts will be paid in respect of this quarterly interim dividend on the relevant payment date:

Per Unilever PLC ordinary share (traded on the London Stock Exchange):

£ 0. 3602

 

Per Unilever PLC ordinary share (traded on Euronext in Amsterdam):

€ 0. 4268

 

Per Unilever PLC American Depositary Receipt:

US$ 0. 4873

 

The euro and US dollar amounts above have been determined using the applicable exchange rates issued by WM/Reuters on
8 February 2022.

US dollar cheques for the quarterly interim dividend will be mailed on 22 March 2022 to holders of record at the close of business on 25 February 2022.

The quarterly dividend calendar for the remainder of 2022 will be as follows:

 

Announcement

Date

Ex-Dividend Date

Record Date

Payment Date

Q4 2021 Dividend

10 February 2022

24 February 2022

25 February 2022

22 March 2022

Q1 2022 Dividend

28 April 2022

19 May 2022

20 May 2022

16 June 2022

Q2 2022 Dividend

26 July 2022

4 August 2022

5 August 2022

1 September 2022

Q3 2022 Dividend

27 October 2022

17 November 2022

18 November 2022

9 December 2022

Unilever will commence a share buyback programme of up to €3 billion, in one or more tranches, to be completed by the end of 2023. The programme is expected to be commence during the first quarter of 2022. Any share buyback tranche commenced after Unilever's 2022 AGM will be dependent on receipt of the relevant AGM authority. A further announcement will be provided before Trading begins.

12  EVENTS AFTER THE BALANCE SHEET DATE

 

On 25 January 2022, Unilever announced changes to its organisational model to make it simpler and more category focused. The company will move away from its current matrix structure and will be organised around five distinct Business Groups: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. Each Business Group will be fully responsible and accountable for their strategy, growth, and profit delivery globally.  We expect the new structure to be fully operational from the middle of the year. All costs related to setting up the new organisation will be managed within the existing restructuring investment plans of €2 billion across 2021 and 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR XKLLBLLLEBBX

a d v e r t i s e m e n t